Zacks Research Brokers Decrease Earnings Estimates for ACHC

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Research analysts at Zacks Research reduced their Q3 2025 earnings per share estimates for shares of Acadia Healthcare in a report released on Wednesday, December 18th. Zacks Research analyst Z. Masood now expects that the company will earn $0.97 per share for the quarter, down from their previous forecast of $0.98. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.91 EPS.

Several other research analysts have also issued reports on the company. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Price Performance

ACHC stock opened at $37.90 on Friday. Acadia Healthcare has a 1 year low of $36.50 and a 1 year high of $87.77. The stock has a market capitalization of $3.52 billion, a PE ratio of 12.43, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company’s 50-day moving average is $43.80 and its 200-day moving average is $60.87. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC grew its position in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after acquiring an additional 241 shares during the period. Blue Trust Inc. grew its holdings in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the period. Commonwealth Equity Services LLC increased its position in Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after buying an additional 257 shares during the last quarter. Atria Investments Inc raised its stake in shares of Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares during the period. Finally, KBC Group NV lifted its position in shares of Acadia Healthcare by 14.4% during the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after buying an additional 338 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.